Veterinary Oncology - Global Strategic Business Report

The global market for Veterinary Oncology was estimated at US$358.2 Million in 2023 and is projected to reach US$727.8 Million by 2030, growing at a CAGR of 10.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

What Is Veterinary Oncology, and Why Is It So Crucial in Animal Healthcare?

Veterinary Oncology is a specialized field of veterinary medicine focused on diagnosing, treating, and managing cancer in animals. It encompasses various treatment modalities such as chemotherapy, radiation therapy, immunotherapy, surgery, and targeted therapy, designed to treat different types of cancers, including lymphomas, mast cell tumors, osteosarcomas, and melanomas in pets, livestock, and even exotic animals. Veterinary oncology aims to extend the lifespan of animals, alleviate pain, and improve the quality of life for cancer patients through early diagnosis, advanced treatment options, and ongoing care.

The importance of veterinary oncology lies in its ability to provide comprehensive cancer care for animals, addressing an increasing prevalence of cancer among companion animals such as dogs and cats, as well as livestock and wildlife. As pets are living longer due to improved healthcare, nutrition, and living conditions, age-related conditions like cancer have become more common. Veterinary oncology offers specialized diagnostic tools, personalized treatment plans, and palliative care, helping pet owners manage complex cancer cases more effectively. With growing awareness of animal welfare and the emotional bond between pet owners and their animals, veterinary oncology has become a vital component of modern veterinary medicine, aligning with broader trends toward more advanced and compassionate care for animals.

How Are Technological Advancements Shaping the Veterinary Oncology Market?

Technological advancements have significantly enhanced the diagnostic, therapeutic, and palliative capabilities of Veterinary Oncology, driving innovation across the field. One of the major developments is the rise of advanced diagnostic imaging technologies, such as computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and ultrasound. These imaging modalities provide detailed insights into tumor size, location, and progression, enabling veterinarians to accurately diagnose cancer, plan treatments, and monitor responses. Imaging-guided biopsies and surgeries have also improved precision, minimizing tissue damage and increasing the likelihood of successful tumor removal.

Advancements in targeted therapies and immunotherapies have transformed veterinary oncology, offering new options for treating cancers in animals. Targeted therapies use drugs designed to attack specific cancer cells without affecting healthy tissues, improving efficacy and reducing side effects. Tyrosine kinase inhibitors (TKIs) and monoclonal antibodies are examples of targeted treatments that are increasingly being used in veterinary oncology, especially for conditions like mast cell tumors and lymphomas. Immunotherapies, which stimulate the animal's immune system to recognize and destroy cancer cells, are also emerging as promising treatments for various types of tumors in animals. Vaccines, such as the melanoma vaccine for dogs, represent a significant breakthrough in using immunotherapy to manage aggressive cancers.

The adoption of precision medicine, including genetic testing and molecular diagnostics, has enabled veterinarians to develop more personalized treatment plans. By analyzing the genetic makeup of tumors, veterinary oncologists can identify specific mutations that guide treatment decisions, increasing the effectiveness of therapies and improving survival rates. The integration of radiation therapy has also advanced, with the use of stereotactic radiation therapy (SRT) and intensity-modulated radiation therapy (IMRT), offering high-dose, targeted treatments that minimize damage to surrounding healthy tissues. These technological innovations not only expand the treatment options available in veterinary oncology but also align with broader trends toward more personalized, precise, and effective cancer care for animals.

What Are the Emerging Applications of Veterinary Oncology Across Different Animal Types?

Veterinary Oncology is finding expanding applications across a variety of animal species, driven by the need for specialized cancer care in both companion and non-companion animals. In companion animals, such as dogs and cats, oncology treatments are commonly used for lymphomas, mast cell tumors, osteosarcomas, and mammary gland tumors. Chemotherapy remains a widely used treatment option, often in combination with surgery or radiation therapy, depending on the type and stage of the cancer. The use of less invasive surgical techniques, such as laparoscopic tumor removal, has also increased in treating small animals, offering quicker recovery times and improved outcomes.

In large animals, including horses and livestock, veterinary oncology is applied to manage conditions such as squamous cell carcinoma, sarcoids, and lymphoma. While the treatment options may differ due to anatomical and physiological variations, advanced therapies like radiation and cryosurgery are employed to treat tumors in horses, improving survival rates and quality of life. Chemotherapy protocols tailored for large animals, combined with supportive care, are also part of veterinary oncology practice for managing certain types of cancers in livestock, particularly those affecting valuable breeding animals.

In exotic animals and wildlife, veterinary oncology has become essential for managing cancers in zoo animals, birds, reptiles, and other species under human care. These animals present unique challenges in cancer treatment due to differences in anatomy, behavior, and immune response, requiring specialized diagnostic and therapeutic approaches. For example, innovative approaches like electrochemotherapy (a combination of chemotherapy and electrical pulses) are used to treat tumors in small mammals and exotic pets, offering an effective and minimally invasive option. The expanding applications of veterinary oncology across diverse animal types underscore its critical role in advancing animal healthcare and improving outcomes for animals with cancer.

What Drives Growth in the Veterinary Oncology Market?

The growth in the Veterinary Oncology market is driven by several factors, including increasing pet ownership, rising awareness of pet health, and advancements in cancer treatment technologies. One of the primary growth drivers is the global rise in pet ownership, with more households viewing pets as family members and seeking advanced healthcare options for them. As the average lifespan of pets increases, the incidence of cancer among companion animals has also risen, creating greater demand for specialized oncology services. Pet owners' willingness to invest in comprehensive cancer care, including diagnostics, treatment, and palliative support, has fueled the demand for veterinary oncology services.

The growing awareness of cancer symptoms and the availability of advanced diagnostic tools have also contributed to market growth. Veterinarians are now able to detect cancers earlier, allowing for more effective treatment plans and better prognoses. The increasing number of veterinary clinics and hospitals offering specialized oncology services, coupled with the rise of veterinary referral centers, has improved access to cancer care for pets. Additionally, the use of telemedicine in veterinary oncology has expanded the reach of expert oncologists, enabling remote consultations, treatment planning, and follow-up care, which enhances access to specialized treatments in underserved areas.

Technological advancements, including targeted therapies, precision medicine, and minimally invasive procedures, have significantly expanded the treatment options available in veterinary oncology, improving success rates and reducing side effects. Regulatory support and funding for veterinary cancer research have also contributed to the development of new drugs and treatments, driving innovation in the field. As the demand for high-quality animal healthcare continues to grow, the Veterinary Oncology market is poised for robust expansion, supported by global trends toward better pet health, increasing awareness of cancer treatments, and a growing focus on personalized care for animals with cancer.

Scope of the Study

The report analyzes the Veterinary Oncology market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments

Therapy (Chemotherapy, Radiology, Immunotherapy, Surgery, Other Therapies); Cancer Type (Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer, Other Cancer Types); Animal Type (Canine, Feline)

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Chemotherapy segment, which is expected to reach US$246.0 Million by 2030 with a CAGR of a 11.8%. The Radiology segment is also set to grow at 9.4% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $93.4 Million in 2023, and China, forecasted to grow at an impressive 14.0% CAGR to reach $168.0 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Veterinary Oncology Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Veterinary Oncology Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Veterinary Oncology Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players in the Global Veterinary Oncology Market such as Accuray, Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health, Elekta AB, Karyopharm Therapeutics, Inc. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 42 companies featured in this Global Veterinary Oncology Market report include:

• Accuray, Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health
• Elekta AB
• Karyopharm Therapeutics, Inc.
• Merck Animal Health
• Torigen Pharmaceuticals
• Varian
• Virbac SA
• Vivesto AB